 |
|
|
| |
Effect of Comedications on Paritaprevir, Ritonavir, Ombitasvir, Dasabuvir and Ribavirin Pharmacokinetics
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy Washington D.C., May 26-28, 2015
A.R. Polepally1, P. S. Badri1, A. Parikh1, L. Rodrigues-Jr2, B. A. Da Silva-Tillmann3, S. Mensing1, T. J. Podsadecki2, W. M. Awni1, S. Dutta1, R. M. Menon1 1AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, IL, 60064; 2AbbVie Inc., Infectious Disease Development, North Chicago, IL, 60064; 3AbbVie Inc., Global Pharmacovigilence, North Chicago, IL, 60064
Clinical Pharm of HIV & Hepatitis Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir: Drug Interactions with Antiretroviral Agents - (06/01/15)
Clinical Pharm of HIV & Hepatitis Assessment of Drug-Drug Interactions Between Daclatasvir and Darunavir/Ritonavir or Lopinavir/Ritonavir - (06/03/15)
|
| |
|
|
|
|
|
